Ivan Spasojevic, PhD

Publications

Jin, Genglin, Christopher J. Pirozzi, Lee H. Chen, Giselle Y. Lopez, Christopher G. Duncan, Jie Feng, Ivan Spasojevic, Darell D. Bigner, Yiping He, and Hai Yan. “Mutant IDH1 is required for IDH1 mutated tumor cell growth..” Oncotarget 3, no. 8 (August 2012): 774–82. https://doi.org/10.18632/oncotarget.577.

PMID
22885298
Full Text

Rajic, Zrinka, Artak Tovmasyan, Ivan Spasojevic, Huaxin Sheng, Miaomiao Lu, Alice M. Li, Edith B. Gralla, David S. Warner, Ludmil Benov, and Ines Batinic-Haberle. “A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity..” Free Radic Biol Med 52, no. 9 (May 1, 2012): 1828–34. https://doi.org/10.1016/j.freeradbiomed.2012.02.006.

PMID
22336516
Full Text

Miriyala, Sumitra, Ivan Spasojevic, Artak Tovmasyan, Daniela Salvemini, Zeljko Vujaskovic, Daret St Clair, and Ines Batinic-Haberle. “Manganese superoxide dismutase, MnSOD and its mimics..” Biochim Biophys Acta 1822, no. 5 (May 2012): 794–814. https://doi.org/10.1016/j.bbadis.2011.12.002.

PMID
22198225
Full Text

Walko, Christine M., Austin J. Combest, Ivan Spasojevic, Angela Y. C. Yu, Shriya Bhushan, J Heyward Hull, Janelle Hoskins, et al. “The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients..” Cancer Chemother Pharmacol 69, no. 5 (May 2012): 1189–96. https://doi.org/10.1007/s00280-011-1815-5.

PMID
22245954
Full Text

Pretty, Jack R., Thomas H. Connor, Ivan Spasojevic, Kristine S. Kurtz, Jeffrey L. McLaurin, Clayton B’Hymer, and D Gayle Debord. “Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment..” J Oncol Pharm Pract 18, no. 1 (March 2012): 23–36. https://doi.org/10.1177/1078155210389215.

PMID
21183556
Full Text

Batinic-Haberle, I., I. Spasojevic, H. M. Tse, A. Tovmasyan, Z. Rajic, D. K. S. Clair, Z. Vujaskovic, M. W. Dewhirst, and J. D. Piganelli. “Erratum: Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities (Amino Acids DOI: 10.1007/s00726-010-0603-6).” Amino Acids 42, no. 1 (January 1, 2012): 115–16. https://doi.org/10.1007/s00726-010-0821-y.

Full Text

Il’yasova, Dora, Ivan Spasojevic, Karel Base, Haoyue Zhang, Frances Wang, Sarah P. Young, David S. Millington, Ralph B. D’Agostino, and Lynne E. Wagenknecht. “Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes..” Diabetes Care 35, no. 1 (January 2012): 173–74. https://doi.org/10.2337/dc11-1502.

PMID
22100959
Full Text

Batinic-Haberle, Ines, Ivan Spasojevic, Hubert M. Tse, Artak Tovmasyan, Zrinka Rajic, Daret K. St Clair, Zeljko Vujaskovic, Mark W. Dewhirst, and Jon D. Piganelli. “Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities..” Amino Acids 42, no. 1 (January 2012): 95–113. https://doi.org/10.1007/s00726-010-0603-6.

PMID
20473774
Full Text

Oberley-Deegan, Rebecca E., Joshua J. Steffan, Kyle O. Rove, Kathryn M. Pate, Michael W. Weaver, Ivan Spasojevic, Barbara Frederick, et al. “The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation..” Plos One 7, no. 9 (2012). https://doi.org/10.1371/journal.pone.0044178.

PMID
22984473
Full Text

Ye, Xiaodong, Diane Fels, Artak Tovmasyan, Katherine M. Aird, Casey Dedeugd, Jennifer L. Allensworth, Ivan Kos, et al. “Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate..” Free Radic Res 45, no. 11–12 (November 2011): 1289–1306. https://doi.org/10.3109/10715762.2011.616199.

PMID
21859376
Full Text

Pages